Literature DB >> 20089078

Impaired host defence against Mycobacterium avium in mice with chronic granulomatous disease.

M Fujita1, E Harada, T Matsumoto, Y Mizuta, S Ikegame, H Ouchi, I Inoshima, S Yoshida, K Watanabe, Y Nakanishi.   

Abstract

Patients with chronic granulomatous disease (CGD), an inherited disorder of phagocytic cells, often contract recurrent life-threatening bacterial and fungal infections. CGD is considered to arise from a functional defect of the O(2)-generating nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in phagocytes. To determine whether or not NADPH oxidase is crucial to the host defence against Mycobacterium avium, we investigated the response against M. avium using CGD model mice (gp91-phox(-)) of C57BL/6 strain. A tracheal injection of 1 x 10(7) colony-forming units (CFU)/head of M. avium strain FN into the CGD mice resulted in a pulmonary infection, while also increasing the mortality rate. In contrast, normal C57BL/6 mice injected with same dose of the organisms did not develop severe pulmonary infection and were able to survive through 2 months of observation. The macrophages obtained from the CGD mice were observed to have a higher burden of the bacterial growth than macrophages from normal C57BL/6 mice. These results suggest that the defect of the NADPH oxidase function impairs the host defence against M. avium infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089078      PMCID: PMC2883117          DOI: 10.1111/j.1365-2249.2010.04092.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Intrapulmonary Mycobacterium avium infection as the first manifestation of chronic granulomatous disease.

Authors:  S Ohga; K Ikeuchi; R Kadoya; K Okada; C Miyazaki; S Suita; K Ueda
Journal:  J Infect       Date:  1997-03       Impact factor: 6.072

Review 2.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

3.  Doxycycline attenuated pulmonary fibrosis induced by bleomycin in mice.

Authors:  Masaki Fujita; Qing Ye; Hiroshi Ouchi; Eiji Harada; Ichiro Inoshima; Kazuyoshi Kuwano; Yoichi Nakanishi
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

4.  Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice.

Authors:  L B Adams; M C Dinauer; D E Morgenstern; J L Krahenbuhl
Journal:  Tuber Lung Dis       Date:  1997

5.  The p47(phox-/-) mouse model of chronic granulomatous disease has normal granuloma formation and cytokine responses to Mycobacterium avium and Schistosoma mansoni eggs.

Authors:  B H Segal; T M Doherty; T A Wynn; A W Cheever; A Sher; S M Holland
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

6.  Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.

Authors:  E Tanaka; T Kimoto; K Tsuyuguchi; I Watanabe; H Matsumoto; A Niimi; K Suzuki; T Murayama; R Amitani; F Kuze
Journal:  Am J Respir Crit Care Med       Date:  1999-09       Impact factor: 21.405

7.  Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.

Authors:  R J Wallace; B A Brown; D E Griffith; W M Girard; D T Murphy
Journal:  Am J Respir Crit Care Med       Date:  1996-06       Impact factor: 21.405

8.  Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis.

Authors:  Pamela P W Lee; Koon-Wing Chan; Liping Jiang; Tongxin Chen; Chengrong Li; Tsz-Leung Lee; Priscilla H S Mak; Susanna F S Fok; Xiqiang Yang; Yu-Lung Lau
Journal:  Pediatr Infect Dis J       Date:  2008-03       Impact factor: 2.129

9.  A novel agar medium to detect hydrogen peroxide-producing bacteria based on the prussian blue-forming reaction.

Authors:  Mitsumasa Saito; Masanori Seki; Ken-Ichiro Iida; Hiroaki Nakayama; Shin-Ichi Yoshida
Journal:  Microbiol Immunol       Date:  2007       Impact factor: 1.955

10.  TNF receptor 1 and 2 contribute in different ways to resistance to Legionella pneumophila-induced mortality in mice.

Authors:  Masaki Fujita; Satoshi Ikegame; Eiji Harada; Hiroshi Ouchi; Ichiro Inoshima; Kentaro Watanabe; Shin-ichi Yoshida; Yoichi Nakanishi
Journal:  Cytokine       Date:  2008-10-05       Impact factor: 3.861

View more
  4 in total

Review 1.  Are reactive oxygen species always detrimental to pathogens?

Authors:  Claudia N Paiva; Marcelo T Bozza
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

2.  The Phagocyte Oxidase Controls Tolerance to Mycobacterium tuberculosis Infection.

Authors:  Andrew J Olive; Clare M Smith; Michael C Kiritsy; Christopher M Sassetti
Journal:  J Immunol       Date:  2018-07-30       Impact factor: 5.422

3.  Mycobacterium tuberculosis nucleoside diphosphate kinase inactivates small GTPases leading to evasion of innate immunity.

Authors:  Jim Sun; Vijender Singh; Alice Lau; Richard W Stokes; Andrés Obregón-Henao; Ian M Orme; Dennis Wong; Yossef Av-Gay; Zakaria Hmama
Journal:  PLoS Pathog       Date:  2013-07-18       Impact factor: 6.823

Review 4.  Towards new TB vaccines.

Authors:  Benedict Brazier; Helen McShane
Journal:  Semin Immunopathol       Date:  2020-03-18       Impact factor: 9.623

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.